Show source-provided references
2. Goetz, M., Thotathil, N., Zhao, Z., and Mitragotri, S. (2024). Vaccine Adjuvants for Infectious Disease in the Clinic. Bioeng. Transl. Med.
10.1002/btm2.10663 ↗3. Targeted and Controlled Drug Delivery System Loading Artersunate for Effective Chemotherapy on CD44 Overexpressing Cancer Cells
10.1007/s12272-016-0738-4 ↗5. Zhang, T., He, P., Guo, D., Chen, K., Hu, Z., and Zou, Y. (2023). Research Progress of Aluminum Phosphate Adjuvants and Their Action Mechanisms. Pharmaceutics, 15.
10.3390/pharmaceutics15061756 ↗8. Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices-United States, 2023
10.15585/mmwr.mm7234a4 ↗9. Park, H.-J., Ko, H.L., Won, D.-H., Hwang, D.-B., Shin, Y.-S., Kwak, H.-W., Kim, H.-J., Yun, J.-W., and Nam, J.-H. (2019). Comprehensive Analysis of the Safety Profile of a Single-Stranded Rna Nano-Structure Adjuvant. Pharmaceutics, 11.
10.3390/pharmaceutics11090464 ↗11. Molecular Engineering Tools for the Development of Vaccines against Infectious Diseases: Current Status and Future Directions
10.1080/14760584.2023.2227699 ↗13. Surface Modification of Poly(Lactic Acid) Nanospheres Using Hydrophobically Modified Dextrans as Stabilizers in an O/W Emulsion/Evaporation Technique
14. Synthesis, Characterization and Evaluation of Novel Triblock Copolymer Based Nanoparticles for Vaccine Delivery against Hepatitis B
10.1016/j.jconrel.2009.02.010 ↗15. Antimicrobial Additives for Poly(Lactic Acid) Materials and Their Applications: Current State and Perspectives
10.1007/s00253-018-9220-1 ↗17. Surfactant-Free Anionic Pla Nanoparticles Coated with Hiv-1 P24 Protein Induced Enhanced Cellular and Humoral Immune Responses in Various Animal Models
10.1016/j.jconrel.2006.02.006 ↗18. Fabrication and Characterization of Ddab/Pla-Alginate Composite Microcapsules as Single-Shot Vaccine
10.1039/C8RA00013A ↗19. Potential Hepatitis B Vaccine Formulation Prepared by Uniform-Sized Lipid Hybrid Pla Microparticles with Adsorbed Hepatitis B Surface Antigen
10.1021/acs.molpharmaceut.8b00722 ↗20. Preventing Surgery-Induced Nk Cell Dysfunction and Cancer Metastases with Influenza Vaccination
21. Cationic Polymer Modified Plga Nanoparticles Encapsulating Alhagi Honey Polysaccharides as a Vaccine Delivery System for Ovalbumin to Improve Immune Responses
10.2147/IJN.S203072 ↗23. The New Era of Vaccines: The “Nanovaccinology”
24. One-Pot Facile Preparation of Peg-Modified Plga Nanoparticles: Effects of Peg and Plga on Release Properties of the Particles
10.1016/j.colsurfa.2015.01.011 ↗26. Renukaradhya, G.J., Wang, W., Huang, B., Jiang, T., Wang, X., Qi, X., Gao, Y., Tan, W., and Ruan, L. (2012). Robust Immunity and Heterologous Protection against Influenza in Mice Elicited by a Novel Recombinant Np-M2e Fusion Protein Expressed in E. coli. PLoS ONE, 7.
10.1371/journal.pone.0052488 ↗27. A Paper-Based Platform for Long-Term Deposition of Nanoparticles with Exceptional Redispersibility, Stability, and Functionality
10.1002/ppsc.201800483 ↗28. Plga Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury
10.1007/s12035-015-9235-x ↗30. (2020). Chinese Pharmacopoeia.
32. Phenotypic Analysis of Ovine Antigen Presenting Cells Loaded with Nanoparticles Migrating from the Site of Vaccination
10.1016/j.ymeth.2013.02.008 ↗